About Conference

The 38th International Conference on Neuroscience and Neurochemistry, set to take place on November 13-14, 2025, in Paris, France, will serve as a premier platform for leading experts, researchers, clinicians, and industry professionals to explore the latest advancements in neuroscience and neurochemistry. The conference aims to foster discussions on cutting-edge research, innovative therapeutic strategies, and ground-breaking developments in the diagnosis, treatment, and management of neurological disorders. With a diverse and multidisciplinary approach, this event will provide an invaluable opportunity for networking, knowledge sharing, and collaboration in the field of brain science. Neuroscience and neurochemistry play a pivotal role in understanding the intricate workings of the brain, neuronal functions, and the chemical processes that underlie cognition, behaviour, and neurological diseases. The 38th International Conference on Neuroscience and Neurochemistry will focus on a wide array of topics, including neurodegenerative diseases, neuroplasticity, molecular and cellular neuroscience, synaptic transmission, neuroimaging techniques, neuropharmacology, and novel therapeutic approaches. The conference will feature keynote lectures, plenary sessions, interactive workshops, and panel discussions, offering a comprehensive learning experience to all attendees.

One of the major objectives of this conference is to address the rising global burden of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, stroke, and neurodevelopmental disorders. The increasing prevalence of these conditions has underscored the need for further research into the molecular mechanisms and biochemical pathways involved in neurodegeneration and neuroprotection. Through this event, experts will present the latest scientific findings and clinical trials, providing insights into potential breakthroughs in treating these disorders.A key highlight of the conference will be its focus on neurotransmitters, synaptic function, and neurochemical signaling pathways that govern brain activity.

Session and Tracks

• Molecular neurochemistry

Molecular neurochemistry is a branch of neuroscience that explores the chemical and molecular mechanisms underlying brain function, neuronal communication, and neurological disorders. It delves into the intricate network of neurotransmitters, neuropeptides, enzymes, and molecular pathways that regulate neural processes, influencing cognition, emotions, and overall brain activity. The brain’s complex biochemical environment relies on tightly regulated interactions between neurotransmitters such as dopamine, serotonin, glutamate, and gamma-aminobutyric acid (GABA), each playing a critical role in synaptic transmission and signal modulation. These chemical messengers enable neurons to communicate, ensuring proper sensory perception, motor coordination, learning, and memory formation. Any disruption in their balance can lead to neurological and psychiatric conditions, including depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. At the core of molecular neurochemistry is the study of synaptic function and plasticity, which determines how neurons strengthen or weaken their connections in response to experiences and external stimuli. Synaptic plasticity is fundamental to learning and memory, with molecules such as brain-derived neurotrophic factor (BDNF) and calcium-calmodulin-dependent protein kinase (CaMKII) playing key roles in long-term potentiation (LTP) and synaptic remodeling. 

• Neurotransmitters & Synapses

Neurotransmitters and synapses play a fundamental role in brain function, serving as the primary mechanisms for neural communication. The human brain consists of billions of neurons that communicate with each other through complex networks, enabling thought processes, emotions, memory, and motor control. This communication occurs at specialized junctions known as synapses, where electrical signals are converted into chemical signals through neurotransmitters. These chemical messengers allow neurons to transmit information across synapses, ensuring seamless coordination of neural activity throughout the nervous system. There are two primary types of synapses: chemical synapses and electrical synapses. Chemical synapses, the most common type, rely on neurotransmitters to carry signals from the presynaptic neuron to the postsynaptic neuron. When an electrical impulse, or action potential, reaches the synaptic terminal, it triggers the release of neurotransmitters stored in vesicles. These neurotransmitters then cross the synaptic cleft and bind to specific receptors on the postsynaptic neuron, initiating a response that either excites or inhibits neural activity. Electrical synapses, on the other hand, use gap junctions that allow ions to flow directly between neurons, enabling rapid and synchronized signalling, which is particularly crucial in reflex pathways and certain brain regions.

• Neurogenetics & Brain Disorders

Neurogenetics is a rapidly advancing field that explores the genetic and molecular mechanisms underlying brain development, function, and disorders. The human brain is an intricate organ shaped by a combination of genetic and environmental factors, and variations in genetic makeup can significantly influence an individual’s susceptibility to neurological and psychiatric conditions. By studying the genetic basis of brain disorders, researchers can identify the root causes of diseases, develop targeted therapies, and enhance early diagnosis and intervention strategies. Genetic mutations, variations, and epigenetic modifications play a crucial role in the onset and progression of numerous brain disorders. Some conditions, such as Huntington’s disease and certain forms of epilepsy, are caused by single-gene mutations, making them relatively straightforward to study. Huntington’s disease, for instance, results from an expansion of CAG repeats in the HTT gene, leading to neurodegeneration and progressive motor and cognitive decline. Similarly, mutations in the SCN1A gene are associated with Dravet syndrome, a severe form of epilepsy that manifests in early childhood. Identifying these genetic mutations has paved the way for targeted gene therapies and precision medicine approaches to treat these disorders. Other neurological conditions, such as Alzheimer’s disease, Parkinson’s disease, and schizophrenia, are more complex and involve multiple genetic and environmental factors. These disorders are often classified as polygenic, meaning that variations in multiple genes contribute to disease risk. 

• Neuropharmacology & Drug Discovery

Neuropharmacology is a dynamic field that explores how drugs influence the nervous system, aiming to develop effective treatments for neurological and psychiatric disorders. By understanding the molecular and cellular mechanisms of brain function, neuropharmacologists can design drugs that target specific neural pathways, neurotransmitter systems, and receptors. With the increasing prevalence of conditions such as Alzheimer’s disease, Parkinson’s disease, epilepsy, depression, and schizophrenia, neuropharmacology plays a crucial role in discovering novel therapeutics to improve brain health and function. One of the primary focuses of neuropharmacology is targeting neurotransmitter systems, which regulate communication between neurons. Many neurological disorders arise from imbalances in neurotransmitters such as dopamine, serotonin, glutamate, GABA, and acetylcholine. For instance, Parkinson’s disease is caused by a loss of dopamine-producing neurons in the substantia nigra, leading to motor impairment. Drugs like levodopa (L-DOPA) help restore dopamine levels, alleviating symptoms. Similarly, selective serotonin reuptake inhibitors (SSRIs), such as fluoxetine and sertraline, are widely used to treat depression and anxiety by increasing serotonin availability in the brain.

• Blood-Brain Barrier & Drug Delivery

The blood-brain barrier (BBB) is a highly selective, protective membrane that regulates the exchange of substances between the bloodstream and the central nervous system (CNS). It plays a crucial role in maintaining brain homeostasis, shielding the brain from harmful toxins, pathogens, and fluctuations in blood composition. However, this protective function also poses a significant challenge in drug delivery, as it restricts the passage of most therapeutic compounds, including those intended for treating neurological disorders such as Alzheimer’s disease, Parkinson’s disease, brain tumors, and epilepsy. Overcoming the BBB remains one of the greatest hurdles in neuropharmacology and drug development. The BBB is primarily composed of endothelial cells, which form tight junctions that prevent the free diffusion of molecules. These endothelial cells are supported by astrocytes, pericytes, and microglia, which collectively help maintain the barrier’s integrity and regulate transport mechanisms. The BBB selectively allows the passage of essential nutrients, such as glucose and amino acids, through specialized transporters while blocking large or hydrophilic molecules. Most conventional drugs fail to penetrate the BBB due to their size, polarity, or lack of specific transport mechanisms. Hydrophilic and large molecules, including many antibodies and peptides, cannot cross the BBB efficiently. 

• Alzheimer’s & Parkinson’s Disease

Alzheimer’s disease (AD) and Parkinson’s disease (PD) are two of the most common neurodegenerative disorders, affecting millions worldwide. Both conditions involve progressive damage to brain cells, leading to cognitive and motor impairments. While they share some similarities, such as abnormal protein accumulation and neuroinflammation, they differ in their primary symptoms and affected brain regions. Alzheimer’s disease is a progressive neurodegenerative disorder primarily affecting memory, thinking, and behavior. It is the leading cause of dementia, accounting for 60-80% of cases. The disease is characterized by the accumulation of beta-amyloid plaques and tau tangles, which disrupt neural communication and lead to neuronal death.The early symptoms of AD include mild memory loss, confusion, and difficulty finding words. As the disease advances, individuals experience severe memory impairment, disorientation, mood changes, and loss of independence. The hippocampus, a region crucial for memory formation, is one of the first areas affected, followed by widespread brain atrophy. Currently, there is no cure for AD, but treatments like cholinesterase inhibitors (e.g., donepezil, rivastigmine) and NMDA receptor antagonists (e.g., memantine) help manage symptoms. Recent advancements in monoclonal antibody therapies, such as aducanumab, aim to target amyloid plaques and slow disease progression. Parkinson’s disease is a chronic movement disorder caused by the degeneration of dopaminergic neurons in the substantia nigra, a brain region responsible for motor control. 

• Neuroinflammation & Immunology

Neuroinflammation is the immune system’s response within the central nervous system (CNS), involving the activation of immune cells in the brain, such as microglia and astrocytes. While acute inflammation plays a protective role in fighting infections and clearing damaged cells, chronic neuroinflammation is linked to various neurological disorders, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis (MS), stroke, and neuropsychiatric conditions. Understanding the intricate relationship between the immune system and the brain is crucial for developing new therapies targeting neuroimmune dysfunction. The brain’s resident immune cells, microglia act as the first line of defense by detecting and responding to infections, injuries, and toxic proteins. Overactivation of microglia can lead to chronic inflammation and neuronal damage. These star-shaped glial cells support neurons, maintain the blood-brain barrier (BBB), and regulate neurotransmitter balance. In inflammatory conditions, astrocytes release pro-inflammatory cytokines, which can contribute to neurodegeneration. These signaling molecules coordinate immune responses. Pro-inflammatory cytokines (e.g., TNF-α, IL-1β, IL-6) drive inflammation, while anti-inflammatory cytokines (e.g., IL-10, TGF-β) help resolve it. The BBB prevents harmful substances from entering the brain, but in neuroinflammatory diseases, it can become leaky, allowing immune cells and toxic proteins to invade the CNS. 

• Stem Cells & Brain Repair

Stem cells hold immense potential for brain repair and neuroregeneration, offering hope for treating neurological disorders and brain injuries. Unlike mature cells, stem cells have the unique ability to self-renew and differentiate into specialized cell types, including neurons, astrocytes, and oligodendrocytes. This ability makes them a promising tool for restoring damaged brain tissue, improving cognitive function, and reversing neurodegenerative diseases. Pluripotent cells that can become any cell type, including neurons. However, their use is limited due to ethical concerns. Reprogrammed adult cells that mimic embryonic stem cells, offering a personalized and ethical alternative. Found in the brain, these cells can generate new neurons and glial cells, particularly in regions like the hippocampus. Found in bone marrow and fat tissue, MSCs can reduce inflammation and support neural repair. While stem cell therapy for brain repair shows great promise, challenges remain, including immune rejection, tumor formation, and limited differentiation efficiency. Ongoing research focuses on enhancing cell survival, targeted delivery, and integration into existing neural networks. Advances in gene editing (CRISPR), biomaterials, and brain organoids are expected to revolutionize regenerative medicine, bringing us closer to effective treatments for brain injuries and neurodegenerative disorders.

• Brain Plasticity & Recovery

The human brain possesses an extraordinary ability to adapt and reorganize itself, a phenomenon known as brain plasticity or neuroplasticity. This adaptive capacity enables the brain to modify its structure and function in response to learning, experiences, environmental changes, injuries, or diseases. Brain plasticity plays a critical role in cognitive development, memory formation, skill acquisition, and most importantly, recovery from neurological damage such as stroke, traumatic brain injury (TBI), neurodegenerative diseases, and spinal cord injuries. Understanding neuroplasticity has transformed approaches to rehabilitation and treatment, offering hope for individuals suffering from brain-related disorders.Brain plasticity operates through several mechanisms that allow neurons to form new connections and reorganize neural pathways. Synaptic plasticity, one of the most fundamental forms, involves changes in the strength and efficiency of synapses, the junctions between neurons where communication occurs. This process is essential for learning and memory, as repeated stimulation of a neural pathway strengthens synaptic connections, a principle known as long-term potentiation (LTP). Conversely, long-term depression (LTD) weakens unused synapses, refining neural circuits to enhance efficiency. Another crucial aspect of brain plasticity is neurogenesis, the birth of new neurons, which primarily occurs in the hippocampus, a region associated with learning and memory. While previously believed to be limited to early development, research has shown that neurogenesis continues into adulthood, playing a vital role in brain repair and recovery.

• Cognitive Neuroscience

Cognitive neuroscience is a multidisciplinary field that explores how brain structures and neural mechanisms give rise to cognitive functions such as perception, attention, memory, language, decision-making, and consciousness. It combines principles from neuroscience, psychology, artificial intelligence, and computational modeling to understand the biological basis of thought and behavior. By investigating how neural circuits process information, cognitive neuroscience provides insights into both normal cognitive function and disorders that impair mental processes, such as Alzheimer’s disease, schizophrenia, and attention deficit disorders.At the core of cognitive neuroscience is the study of brain regions and networks responsible for cognition. Modern neuroimaging techniques such as functional magnetic resonance imaging (fMRI), positron emission tomography (PET), electroencephalography (EEG), and magnetoencephalography (MEG) allow researchers to visualize and measure brain activity in real time. These tools have revealed the intricate connections between different brain regions, such as the prefrontal cortex (involved in decision-making and executive functions), the hippocampus (crucial for memory formation), and the amygdala (regulating emotions and social behavior). One of the fundamental areas of cognitive neuroscience is the study of memory and learning. Researchers investigate how short-term memories are stored in the prefrontal cortex and how long-term memories are consolidated in the hippocampus. Understanding the neural basis of memory has significant implications for treating conditions like dementia and amnesia, as well as for developing brain-computer interfaces that enhance cognitive abilities. 

• Stroke & Neurological Disorders

Stroke and neurological disorders are among the leading causes of disability and death worldwide, affecting millions of people each year. A stroke occurs when blood flow to the brain is disrupted, either due to a blockage (ischemic stroke) or a ruptured blood vessel (hemorrhagic stroke). This interruption deprives brain cells of oxygen and nutrients, leading to cell death and loss of neurological function. The severity of a stroke depends on the area of the brain affected, with symptoms ranging from paralysis, speech impairment, memory loss, and cognitive decline to life-threatening complications. Immediate medical intervention, including thrombolytic therapy, mechanical thrombectomy, and neuroprotective treatments, is crucial to minimizing damage and improving recovery outcomes. Beyond stroke, a wide range of neurological disorders impact brain function, including Alzheimer’s disease, Parkinson’s disease, multiple sclerosis (MS), epilepsy, and amyotrophic lateral sclerosis (ALS). These conditions may result from genetic mutations, infections, autoimmune responses, neurodegeneration, or traumatic brain injury (TBI). Many neurological disorders are progressive and irreversible, leading to cognitive, motor, and sensory impairments that significantly affect quality of life. Advances in neuroimaging, biomarker research, and personalized medicine are helping to improve early diagnosis and targeted treatment approaches.

• Epigenetics & Brain Development

Epigenetics plays a crucial role in brain development, influencing how genes are expressed without altering the underlying DNA sequence. It involves chemical modifications such as DNA methylation, histone modifications, and non-coding RNA mechanisms, which regulate gene activity in response to environmental factors. These modifications are particularly significant during early brain development, as they guide processes like neuronal differentiation, synapse formation, and cognitive function. Proper epigenetic regulation is essential for normal brain growth, learning, and memory, while disruptions can lead to neurodevelopmental disorders such as autism spectrum disorder (ASD), schizophrenia, and intellectual disabilities. During fetal development and early childhood, the brain undergoes rapid growth and plasticity. Environmental influences such as nutrition, stress, toxins, and parental care can modify epigenetic patterns, shaping brain structure and function. For instance, maternal stress or malnutrition during pregnancy can alter DNA methylation in fetal brain cells, increasing the risk of cognitive and emotional disorders later in life. Similarly, early childhood experiences, including learning, social interactions, and trauma, can leave lasting epigenetic marks that affect behaviour and mental health. Emerging research in epigenetic therapy aims to reverse harmful epigenetic changes through interventions such as dietary modifications, pharmacological agents, and lifestyle changes. Understanding the epigenetic basis of brain disorders opens new avenues for treating conditions like Alzheimer’s disease, depression, and epilepsy.

• Neuroendocrinology & Hormones

Neuroendocrinology is the study of the intricate interactions between the nervous system and the endocrine system, focusing on how hormones regulate brain function and influence behavior. The hypothalamus, a small but crucial brain structure, acts as the primary control center, linking the brain to the endocrine system via the pituitary gland. Through this connection, the brain communicates with various glands, including the adrenal glands, thyroid gland, and gonads (testes and ovaries), to regulate essential physiological processes such as growth, metabolism, stress response, reproduction, and mood.Hormones play a critical role in brain development, cognition, and emotional regulation. For example, cortisol, the primary stress hormone, is released by the adrenal glands in response to signals from the hypothalamus-pituitary-adrenal (HPA) axis. While short-term cortisol release is essential for adaptive responses to stress, chronic overactivation of the HPA axis can lead to anxiety, depression, cognitive impairment, and neurodegenerative diseases. Similarly, thyroid hormones, produced by the thyroid gland, are crucial for brain development, and imbalances in these hormones can lead to intellectual disabilities, mood disorders, and impaired cognitive function.

• Neuroimaging & Biomarkers

Neuroimaging and biomarkers play a crucial role in understanding brain function, diagnosing neurological disorders, and developing targeted treatments. Neuroimaging techniques provide a non-invasive way to visualize brain structure, activity, and connectivity, offering valuable insights into normal brain function and disease progression. Advanced imaging technologies such as magnetic resonance imaging (MRI), functional MRI (fMRI), positron emission tomography (PET), and diffusion tensor imaging (DTI) allow researchers and clinicians to detect abnormalities associated with conditions like Alzheimer’s disease, Parkinson’s disease, stroke, epilepsy, and multiple sclerosis (MS). These techniques help identify structural and functional changes in the brain, enabling early diagnosis and monitoring disease progression.Biomarkers, on the other hand, are measurable biological indicators that provide information about brain health and disease states. They can be found in blood, cerebrospinal fluid (CSF), and neuroimaging data. For example, in Alzheimer’s disease, amyloid-beta and tau proteins serve as biomarkers, helping in early detection and tracking disease progression. Similarly, biomarkers like neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) are used to assess neurodegeneration and brain injury. In stroke, biomarkers such as D-dimer and C-reactive protein (CRP) help determine the severity and risk of recurrence.

• AI in Neuroscience

Artificial Intelligence (AI) is revolutionizing neuroscience by enhancing our ability to analyze complex brain data, diagnose neurological disorders, and develop personalized treatments. AI-driven technologies, including machine learning (ML), deep learning, and neural networks, are being applied to neuroimaging, neurophysiology, and computational neuroscience, offering new insights into brain function and disease mechanisms. Advanced AI algorithms can process vast amounts of neuroimaging data from MRI, fMRI, PET, and EEG scans, allowing for early detection of disorders such as Alzheimer’s disease, Parkinson’s disease, epilepsy, and stroke. By recognizing subtle patterns that may be undetectable to human experts, AI improves diagnostic accuracy and speeds up clinical decision-making. AI is also transforming brain-computer interfaces (BCIs), enabling direct communication between the brain and external devices. These advancements have profound implications for individuals with paralysis, spinal cord injuries, or neurodegenerative diseases, allowing them to regain movement and communication abilities. AI-powered speech synthesis and neuroprosthetics are also helping patients with conditions like amyotrophic lateral sclerosis (ALS) and locked-in syndrome.

• Neurodegeneration & Aging

Neurodegeneration and aging are closely linked processes that contribute to cognitive decline, motor impairment, and an increased risk of neurological disorders. As the brain ages, it undergoes structural, functional, and biochemical changes that affect memory, learning, and overall neurological health. While mild cognitive decline is a normal part of aging, pathological neurodegeneration leads to diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis (ALS). These conditions are characterized by progressive loss of neurons, accumulation of toxic proteins, mitochondrial dysfunction, oxidative stress, and chronic neuroinflammation. One of the hallmarks of age-related neurodegenerative diseases is the buildup of misfolded proteins. In Alzheimer’s disease, amyloid-beta plaques and tau tangles disrupt neuronal communication and lead to memory loss. In Parkinson’s disease, alpha-synuclein aggregates (Lewy bodies) damage dopamine-producing neurons, causing tremors and motor impairment. Similarly, Huntington’s disease is caused by an abnormal expansion of the huntingtin gene, leading to severe cognitive and motor deficits. These diseases share common pathological mechanisms, including protein aggregation, synaptic dysfunction, and neuronal death, making them difficult to treat.

• Psychiatric Disorders

Psychiatric disorders are complex mental health conditions that affect emotions, thoughts, and behavior, significantly impacting an individual’s daily life. These disorders arise from a combination of genetic, neurobiological, environmental, and psychological factors, disrupting normal brain function and leading to cognitive and emotional impairments. Psychiatric illnesses range from mood disorders, anxiety disorders, and psychotic disorders to personality disorders and neurodevelopmental conditions.One of the most prevalent psychiatric disorders is depression, characterized by persistent sadness, loss of interest, and cognitive dysfunction. Bipolar disorder involves extreme mood swings between depressive and manic episodes, disrupting emotional stability. Anxiety disorders, including generalized anxiety disorder (GAD), panic disorder, and obsessive-compulsive disorder (OCD), cause excessive fear and stress, often interfering with daily functioning. Schizophrenia and other psychotic disorders involve hallucinations, delusions, and cognitive impairments, profoundly affecting perception and reality. Personality disorders, such as borderline personality disorder (BPD) and antisocial personality disorder (ASPD), lead to maladaptive behaviors and interpersonal difficulties. Additionally, neurodevelopmental disorders like autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) impact social interaction, learning, and executive function.

• Gut-Brain Axis

The gut-brain axis is a bidirectional communication network connecting the gastrointestinal system and the central nervous system (CNS). This intricate connection involves the nervous system, immune system, endocrine pathways, and gut microbiota, playing a crucial role in brain function, mental health, and overall well-being. Emerging research has revealed that the gut microbiome, composed of trillions of microorganisms, profoundly influences mood, cognition, behavior, and neurological disorders.The vagus nerve serves as a key communication channel in the gut-brain axis, transmitting signals between the gut and the brain. Additionally, the enteric nervous system (ENS), often referred to as the "second brain," regulates digestion and interacts with the CNS to influence emotions and stress responses. Gut microbes produce neurotransmitters such as serotonin, dopamine, and gamma-aminobutyric acid (GABA), which directly impact mood, anxiety, and cognitive function. In fact, nearly 90% of the body's serotonin is produced in the gut, highlighting its critical role in mental health.

• Neurotoxicology & Environment

Neurotoxicology is the study of how environmental toxins and chemicals affect the nervous system, leading to cognitive, behavioral, and motor impairments. The brain and nervous system are highly sensitive to toxic substances, which can interfere with neuronal function, disrupt neurotransmitter signaling, and cause long-term damage. Exposure to neurotoxic agents can occur through air, water, food, and occupational settings, contributing to the development of neurodegenerative diseases, developmental disorders, and mental health conditions. Common environmental neurotoxins include heavy metals (lead, mercury, arsenic), pesticides, industrial chemicals (polychlorinated biphenyls, dioxins), air pollutants, and certain pharmaceuticals. Heavy metal exposure, especially during early brain development, has been linked to cognitive deficits, reduced IQ, and neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). Pesticides and herbicides, such as organophosphates, have been associated with Parkinson’s disease and neurodegenerative decline due to their ability to induce oxidative stress and mitochondrial dysfunction. Air pollution, particularly fine particulate matter (PM2.5) and nitrogen dioxide (NO2), has been linked to increased risks of stroke, Alzheimer’s disease, and cognitive decline.

• Sleep & Circadian Rhythms

Sleep and circadian rhythms play a crucial role in maintaining brain function, cognitive performance, and overall well-being. Sleep is a complex, dynamic process essential for memory consolidation, emotional regulation, neural repair, and detoxification of metabolic waste. Circadian rhythms, often referred to as the biological clock, regulate sleep-wake cycles and synchronize physiological processes with environmental cues such as light and darkness. Disruptions in sleep and circadian rhythms are linked to various neurological, psychiatric, and metabolic disorders.The brain undergoes distinct stages of sleep, including rapid eye movement (REM) sleep and non-REM sleep, each serving critical functions. REM sleep is associated with dreaming, emotional processing, and creativity, while deep non-REM sleep supports memory consolidation, synaptic pruning, and cellular repair. The glymphatic system, a waste clearance system in the brain, is highly active during sleep, removing neurotoxic proteins like beta-amyloid, which are implicated in Alzheimer’s disease. Circadian rhythms are governed by the suprachiasmatic nucleus (SCN) of the hypothalamus, which responds to light signals from the retina. The hormone melatonin, produced by the pineal gland, plays a key role in regulating sleep cycles.

• Pain & Neurochemistry

Pain is a complex neurological process involving the activation, modulation, and transmission of signals within the nervous system. It serves as a crucial protective mechanism, alerting the body to potential harm. The field of pain neurochemistry explores the molecular and biochemical pathways underlying pain perception, including the role of neurotransmitters, receptors, and signaling molecules in pain processing. Dysregulation of these mechanisms can lead to chronic pain conditions, neuropathic pain, and inflammatory disorders. Pain perception begins with the activation of nociceptors, specialized sensory neurons that detect noxious stimuli such as heat, pressure, and chemical irritants. These neurons transmit signals via the spinal cord to the brain, where pain is processed and interpreted. Neurotransmitters such as glutamate, substance P, and calcitonin gene-related peptide (CGRP) play key roles in amplifying pain signals, while inhibitory neurotransmitters like gamma-aminobutyric acid (GABA) and endogenous opioids (endorphins and enkephalins) help modulate and suppress pain. The brain's descending pain modulation system involves neurotransmitters like serotonin, norepinephrine, and dopamine, which can either enhance or inhibit pain perception. Chronic pain disorders, such as fibromyalgia, neuropathic pain, and migraine, are often linked to imbalances in these neurochemical pathways. Neuroinflammation, involving the release of cytokines and prostaglandins, further contributes to persistent pain by sensitizing nociceptors and disrupting normal pain regulation.

• Brain-Computer Interface

Brain-Computer Interfaces (BCIs) are revolutionary technologies that enable direct communication between the brain and external devices. BCIs work by detecting neural activity, processing brain signals, and translating them into commands that can control computers, prosthetic limbs, or assistive communication systems. This cutting-edge field combines neuroscience, engineering, artificial intelligence (AI), and signal processing to develop life-changing applications for individuals with neurological disorders, paralysis, and communication impairments.BCIs operate by recording electrical signals from the brain, primarily using electroencephalography (EEG), electrocorticography (ECoG), or implanted microelectrodes. These signals are then interpreted through machine learning algorithms that decode brain activity and convert it into digital commands. Non-invasive BCIs use EEG caps to capture brain signals externally, while invasive BCIs, often implanted in the brain, provide more precise signal detection but require surgical intervention. Individuals with conditions like amyotrophic lateral sclerosis (ALS), spinal cord injuries, or locked-in syndrome can use BCIs to control speech-generating devices, robotic arms, or wheelchairs using only their thoughts. BCIs also have potential applications in stroke recovery, helping patients regain motor control through neural feedback and stimulation therapies.

• Neuroengineering & Prosthetics

Neuroengineering & Prosthetics is a rapidly evolving field that merges neuroscience, bioengineering, and robotics to develop advanced technologies that restore lost sensory and motor functions. This interdisciplinary area focuses on designing neural implants, brain-controlled prosthetic limbs, and neurostimulation devices to help individuals with neurological disorders, amputations, or spinal cord injuries regain mobility and independence.At the core of neuroengineering is the development of brain-machine interfaces (BMIs) and neuroprosthetics, which connect the nervous system to external devices. These systems work by recording electrical signals from the brain, spinal cord, or peripheral nerves, decoding the signals through artificial intelligence (AI) algorithms, and using them to control robotic limbs, exoskeletons, or communication devices. Electroencephalography (EEG), electromyography (EMG), and implantable electrodes are commonly used to capture neural activity and translate it into precise motor commands. Sensory feedback integration, where artificial limbs provide real-time touch and temperature sensations to the user, is also being explored to create a more natural experience. Innovations in spinal cord stimulation and neural bypass technologies offer hope for individuals with paralysis, allowing them to regain movement through brain-controlled exoskeletons and electrical stimulation of the nervous system.

• Gene Therapy in Neurology

Gene therapy in neurology is an innovative approach that aims to treat or prevent neurological disorders by modifying or replacing faulty genes within the nervous system. This cutting-edge field holds the potential to correct genetic mutations, restore neuronal function, and slow the progression of neurodegenerative diseases, offering new hope for patients with conditions that were previously considered untreatable.Gene therapy works by delivering functional genetic material into targeted cells using vectors, most commonly adeno-associated viruses (AAVs) or lentiviruses. These vectors are designed to introduce, delete, or modify genes within the central nervous system (CNS) to restore normal cellular function. In neurology, gene therapy has been particularly promising for inherited disorders, neurodegenerative diseases, and neurodevelopmental conditions. Gene therapy is also being explored for Parkinson’s disease, aiming to restore dopamine production by delivering key enzymes directly into the brain. Similarly, for Huntington’s disease, gene silencing techniques using RNA interference (RNAi) or CRISPR-based gene editing are being developed to suppress the mutant HTT gene, which causes neuronal degeneration.

Market Analysis

The 38th International Conference on Neuroscience and Neurochemistry serves as a vital global platform for researchers, scientists, and healthcare professionals to discuss cutting-edge advancements in neuroscience and neurochemical research. The global neuroscience market has experienced substantial growth due to increasing cases of neurological disorders such as Alzheimer's, Parkinson’s, and epilepsy, with market valuation expected to rise from $30 billion in 2020 to over $50 billion by 2030. Neurochemical drug research and technological advancements, including AI-driven neuroscience, neuroimaging, and biomarker analysis, are key drivers of industry growth. Additionally, conference participation has steadily increased due to heightened global interest, with projected attendance surpassing 2,500 researchers by 2030.

Key market drivers include the growing prevalence of neurological disorders, increased government and private funding for neuroscience R&D, pharmaceutical industry investments in neurochemical drug development, and advancements in neuroimaging and biomarker technology. Regionally, North America dominates the market due to strong research infrastructure, funding, and top-tier universities, while Europe sees significant growth in neurochemistry research, especially in Germany, France, and the UK. The Asia-Pacific region represents the fastest-growing market due to rising neurological disorder prevalence and government initiatives in China, Japan, and India. Latin America and the Middle East are emerging players, with Brazil and the UAE leading neuroscience research efforts, whereas Africa is gradually expanding its initiatives, with South Africa playing a key role.

The competitive landscape comprises top academic institutions like Harvard, Oxford, and Stanford, leading pharmaceutical companies such as Pfizer, Eli Lilly, and Novartis, and numerous emerging biotech startups contributing to neurochemical advancements. The future outlook from 2025 to 2030 anticipates increased global collaboration, expansion of personalized medicine for neurological disorders, and the integration of AI and machine learning into neuroscience research. The demand for international neuroscience-related conferences is also expected to grow, with digital and hybrid formats reaching broader global audiences.

The neuroscience and neurochemistry industry is set for substantial growth, driven by increasing investments, technological breakthroughs, and the rising need for innovative neurological disorder treatments worldwide. The 38th International Conference on Neuroscience and Neurochemistry will continue to serve as a crucial event for fostering global collaboration and innovation in this rapidly evolving field.

Past Confernece

We welcome you and appreciate your participation at the 37th International Conference on Neuroscience and Neurochemistry, which is going to be held during August 01-02, 2022 Zurich, Switzerland and will be organized around the theme “Translational Neuroscience Research and Reviews".

Our Neuroscience organizing committee of Neuroscience 2022 is looking forward to see you with you modernism and most enlightened topics which are going to help the world clinicians to upgrade their skills and facsimile the research in upgraded version.

Neuroscience is a wing which inter-related too many studies such as: Affective neuroscience, Behavioural neuroscience, Cellular neuroscience, Clinical neuroscience, Cognitive neuroscience, Computational neuroscience, Cultural neuroscience, Developmental neuroscience, Evolutionary neuroscience, Molecular neuroscience, Neuralengineering, Neuroanatomy, Neurochemistry, Neuroethology, Neurogastronomy, Neurogenetics, Neuroimaging, Neuroimmunology, Neuroinformatics, Neurolinguistics, Neurophysics, Neurophysiology, Neuropsychology, Paleoneurobiology, Social neuroscience, Systems neuroscience.